GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.

Samsung is committed to create a new future for medical professionals and patients with a mission to bring health and well-being to people’s lives. With this in mind, Samsung Medison, an ultrasound company based in South Korea, is part of this commitment by providing innovative products and solutions for these medical professionals and patients, as well as by supporting life-long healthcare for women by pursuing innovative healthcare solutions in Ob/Gyn ultrasound.

With integration of Samsung’s state-of-the-art technologies in the field of IT, image signal processing, semiconductors and communications, Samsung Medison develops ultrasound AI diagnostic technologies in radiology, OB/GYN, orthopedics and etc, as well as ultrasound machines for fast and accurate diagnosis. In addition, Samsung Medison focuses on guaranteeing efficient workflows and differentiated diagnostic solutions for user conveniences by collaborating with various global enterprises.

Clinical research activities are also performed with worldwide prestigious KOLs to enhance and improve "Access" for easy and quick approach to patients and "Accuracy" for accurate diagnostics not only during examinations, but also in emergency cases and etc. "Efficiency" is also another keyword to improve the conveniences of hospitals and medical professionals. These 3 key words - "Access", "Accuracy" and "Efficiency" are the areas Samsung will continue to focus on and innovate to provide new experiences that goes beyond what medical professionals and patients have experienced before.

Samsung Medison is the innovator in the ultrasound field to support healthcare professionals, will always be there to build a healthier future with continuous researches and innovations.

At Revvity, “impossible” is inspiration, and "can’t be done" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialization in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharma and biotech, diagnostic labs, academia and governments. Revvity is part of the S&P 500 index and has customers in more than 190 countries.

Revvity products were chosen as the principal screening tool for the ASPRE study. Throughout the study, the Revvity’s DELFIA® Xpress PlGF 1-2-3TM assay was used as an aid in screening for pre-eclampsia in conjunction with maternal history, mean arterial blood pressure (MAP) measurement, and uAD (Uterine Artery Doppler). In 2022, Revvity’s DELFIA® Xpress PlGF 1-2-3TM and DELFIA® Xpress sFlt-1/PlGF Ratio were approved for inclusion in NICE DG-49 diagnostic guidance “PlGF based testing to help diagnose suspected preterm preeclampsia.”

To help facilitate wider access to non-invasive prenatal testing for pregnant women, Revvity offers an easy to use, cost-effective, high-throughput screening system. The Vanadis® cfDNA system is an automated non-sequencing, non-PCR based solution for cfDNA analysis.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at https://innovativemedicine.jnj.com/emea/

Follow us at J&J Innovative Medicine Europe, Middle East & Africa (EMEA).

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, MR, X-Ray, Ultrasound and Healthcare Informatics across the globe.
In line with our Made for Life philosophy, patients are at the heart of everything we do.
Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide.
Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

At Canon Medical we work hand in hand with our partners – our medical, academic and research community.
We build relationships based on transparency, trust and respect.
Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life

SonoScape Medical Corp. stands as a prominent innovator in medical technology, specializing in ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery (MIS), and cardiovascular intervention solutions. Offering professional medical solutions and support in over 170 countries, SonoScape is driven by a passion for continuous innovation, unlocking life's potential and paving the way for boundless advancements in healthcare.

B·R·A·H·M·S GmbH, part of Thermo Fisher Scientific, investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for prenatal screening, cardiovascular, pulmonary, and cancer disorders as well as for sepsis, the company contributes to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our know-how and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

The B·R·A·H·M·S KRYPTOR platforms and the B·R·A·H·M·S biomarkers for prenatal screening are CE certified and approved by the Fetal Medicine Foundation (FMF), the portfolio comes up to the quality standards of the FMF since 1999.

VOLUTRACER OPUS ® is a high-fidelity ultrasound optical positioning simulator. It is the perfect solution for the education and training of students, residents and experts of all levels. Uses real high resolution 2D cases. It has an online Cloud, to download courses, normal and pathological, in a wide range of anatomical regions. It is an open platform that allows the user to create their own content using their own case library. Thanks to its optical positioning scanning system, it allows 6 degrees of freedom of the hand making the practice a realistic experience. Simple and lightweight, VOLUTRACER OPUS ® is perfect for practicing everywhere, whether at home, classroom, workshops and more. Everything that can be scanned can be trained in VOLUTRACER OPUS ®.

Thousands of expectant mothers are already using Pulsenmore’s home ultrasound to stay connected to their care teams—safely, confidently, and from the comfort of home. Designed to complement traditional care, Pulsenmore enables clinicians to deliver continuous, personalized support between visits.

With a compact device that connects to a patient’s smartphone and step-by-step guidance via an intuitive app, high-quality scans are captured at home and securely reviewed—synchronously or asynchronously—via a clinician dashboard. This workflow increases flexibility, reduces unnecessary visits, and enhances patient engagement.

Obstetric ultrasound is one of the most powerful tools in prenatal care, but also one of the most complex. It requires precision, attention and deep expertise — for every exam. At Diagnoly, we believe that AI-powered solutions can help to enhance quality and efficiency in your ultrasound lab.

That’s why we built Fetoly, a real-time medical copilot supporting you during your fetal ultrasound examination. Fetoly is a mobile application developed by a team of doctors and mathematicians, passionate about making fetal screening more accurate, consistent and accessible. It connects to any major ultrasound system and runs directly on your tablet or smartphone — without disrupting your workflow or modifying your habits.

No cloud, no internet dependency, no compromise: All processing happens locally on your device. Your data never leaves the hospital — keeping it safe, secure and compliant.

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

astraia software gmbh provides software solutions in obstetrics and gynaecology for structured documentation and reporting, as well as for scientific studies. The company was founded in 2000 and is based in Ismaning (Munich), Germany. A dedicated team of about 30 employees serves more than 1,700 customers in over 75 countries. In many countries, astraia is also represented by local sales partners.

We are supported by leading experts from all over the world to guarantee a comprehensive, practical and efficient documentation of the examinations with advanced medical functionalities, based on the latest knowledge and standardized terminology in around 20 languages.

Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions. Firmly committed to our mission of “advance medical technologies to make healthcare more accessible”, we are dedicated to innovation in Medical Imaging System.

Mindray possesses a sound global R&D, marketing and service network. Inspired by the needs of our customers, we adopt advanced technologies and transform them into accessible innovation, bringing healthcare within reach. Today, Mindray’s products and services can be found in healthcare facilities in over 190 countries and regions.

Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Learn more about us at www.labcorp.com.